# Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

> **NCT07057765** · — · RECRUITING · sponsor: **Ain Shams University** · enrollment: 40 (estimated)

## Conditions studied

- DLBCL - Diffuse Large B Cell Lymphoma
- Markers of Inflammation

## Interventions

- **DRUG:** Observational Assessment of Standard R-CHOP Treatment

## Key facts

- **NCT ID:** NCT07057765
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-05
- **Primary completion:** 2026-05
- **Final completion:** 2026-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07057765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07057765, "Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07057765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*